well gkm, pretty much what i expected from you...it's not me...

well gkm, pretty much what i expected from you...

it's not me harping on about delay, it's about a ceo, the face of a company, the 'professional' who approves the wording of market announcements - who repeatedly now has shown himself prepared to overstate, overhype, over-estimate too many critical milestones - he's a hype salesman who uses the wrong words, verging on being false and misleading... that his use of incorrect terminology results in delays is a direct symptom of his mode of management, or mis-management from where i sit...

but he has you in his corner, so all is good in the world of biotechs, because you know biotechs, and the way they work - truly a sensational expertise you have there gkm

as for your investment advice, and particular in respect of biotechs, and especially TIS.. well i wouldn't be the first here to tell you to save it for yourself, mate

anyhoos, have a superb weekend reading up on, and reading between the lines of the aussie biotech community - your crystal ball really is something else...

good luck